Hakeem Ayinde, MD
Clinical Cardiac Electrophysiology · Fredericksburg, VANPI 1366706111
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medtronic at 32.4% of the total. 2025 is the largest year on record at $7,804, 2.6 times the $3,003 reported in 2019.
Across 513 payments — averaging $50.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Biosense Webster, Inc.$6K
- Biotronik Inc.$4K
- Atricure, Inc.$1K
- Boston Scientific$1K
- Medical Device Business Services, Inc.$1K
- plus $4K from 22 others
Across 1 payment — averaging $8500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$9K
What the payments were for
- Consulting fees$9003%
- Travel & lodging$10,29040%
- Food & beverage$14,63256%
- Education$930%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 167 | $8,398 |
| Biosense Webster, Inc. | 170 | $5,739 |
| Biotronik Inc. | 47 | $3,986 |
| Atricure, Inc. | 12 | $1,467 |
| Boston Scientific | 18 | $1,465 |
| Medical Device Business Services, Inc. | 2 | $1,341 |
| Abbott | 25 | $1,334 |
| Bayer | 4 | $367 |
| Philips North America LLC | 4 | $299 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $250 |
| Edwards Lifesciences | 2 | $239 |
| Cardiva Medical, Inc. | 8 | $158 |
| Novo Nordisk | 3 | $141 |
| Johnson & Johnson | 8 | $131 |
| AstraZeneca | 5 | $109 |
| Alnylam Pharmaceuticals Inc. | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $89 |
| Pfizer | 5 | $83 |
| Amgen | 2 | $35 |
| Novartis | 2 | $33 |
| Cvrx, Inc. | 2 | $27 |
| Penumbra, Inc. | 1 | $25 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Heartflow, Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Impulse Dynamics (USA) Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Altathera Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$4,210
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,034
- GENERAL - THERAPIES$957
- EVERA MRI XT DR SURESCAN$935
- Solia$820
- Edora 8 DR-T$820
- BioMonitor$820
- Rivacor 7 DR-T$820
- Acticor 7 VR-T DX$820
- SYNERGY ABLATION SYSTEM$667
- COBALT DR MRI SURESCAN$398
- ENSITE$377
- ENSITE PRECISION$336
- Kerendia$263
- ATRICLIP LAA EXCLUSION SYSTEM$222
- Micra$166
- EPI-SENSE GUIDED COAGULATION SYS$145
- Edwards SAPIEN 3 Transcatheter Heart Valve$143
- PulseSelect$136
- Smartablate$106
How this compares
$25,915 in reported general payments places this provider in the 55th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 209 | $244,790 |
| FarxigaDapagliflozin Propanediol | 45 | $45,550 |
| EntrestoSacubitril/Valsartan | 34 | $33,565 |
| XareltoRivaroxaban | 24 | $26,137 |
| Flecainide Acetate | 205 | $6,279 |
| Propafenone Hcl ErPropafenone Hcl | 17 | $3,286 |
| Amiodarone Hcl | 111 | $2,602 |
| Metoprolol Succinate | 110 | $1,538 |
| Sucralfate | 63 | $1,191 |
| SotalolSotalol Hcl | 55 | $1,092 |
| Pantoprazole Sodium | 100 | $1,042 |
| Midodrine Hcl | 16 | $920 |
| Atorvastatin Calcium | 57 | $872 |
| Bumetanide | 30 | $841 |
| Losartan Potassium | 60 | $631 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $244,790209 claims |
| AstraZenecaFarxiga | $109 | $45,55045 claims |
| NovartisEntresto | $33 | $33,56534 claims |
| Johnson & JohnsonXarelto | $131 | $26,13724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Fredericksburg
- Peem LorvidhayaFredericksburg$230K
- Ashok TalrejaFredericksburg$32K
- Kenneth EllenbogenRichmond$360K
- Brett AtwaterFairfax$319K
- Oliver MonfrediCharlottesville$231K
- Erich KiehlNewport News$181K
- Emmanuel EkanemWinchester$132K
- Pamela MasonCharlottesville$130K
- Ajay PillaiRichmond$129K
- Stephen GaetaFairfax$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.